Age Related Macular Degeneration May be Prevented with Macugen
Age-related macular degeneration (AMD) is the leading cause of blindness in older patients in US and the developed world. Pegaptanib sodium (Macugen) is a new treatment for exudative AMD, and has been shown to stabilize vision in approximately 70 percent of cases.
Read the article here.
Filed under Eye Treatment, Health
You may also like to read
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration
- Don’t Take Health Of Your Eyes For Granted
- Diabetes Drug Avandia Causing Macular Edema
- Reappearance of Inturned Eyelashes May be Prevented by Azithromycin
- Dry Eye Syndrome in Women May be Prevented by Regulating Fatty Acid Intake
April 14th, 2008 at 9:15 am
It is great to see that people are getting the word out on Macular Degeneration and the effects that this has on all aspects of life.
The key is early detection and reducing the associated risks of contracting macular degeneration.
This hit very close to home last year in April 2007 when my mom was diagnosed with this condition. Luckily, she was a candidate for avastin treatments here in Newfoundland, Canada, but these were not covered by our provincial healthcare system. Family and friends kicked in to save her vision!
Treatments for macular degeneration, at least the wet form of macular degeneration exist now, including drugs such as lucentis, avastin and macugen.
It is important to advocate a healthier lifestyle and regular eye exams to protect ourselves from this disease.
Barry Wheeler
http://www.amdsupport.ca